GLP-1 hunger control claims on TikTok: what holds up?

What did @angelica_olivas actually say?

She picked up an over-the-counter supplement because it said "Appetizer control" on the label, and explained she wants "something that works like the GLP-1" to stop snacking since becoming a stay-at-home mom. That's the whole claim: a store-bought supplement can replicate the hunger-suppressing mechanism of GLP-1 receptor agonists like semaglutide or tirzepatide.

To be fair, she's not selling anything or citing fake research. She's a consumer making a relatable, if medically shaky, leap in logic. The problem is that the gap between "says appetite control on the label" and "works like a GLP-1" is enormous, and that gap can lead people away from treatments that actually have evidence behind them.

Does the science back this up?

No. Not in any meaningful clinical sense. GLP-1 receptor agonists work by binding to specific receptors in the gut, pancreas, and brain to slow gastric emptying, reduce appetite signaling, and modulate dopamine-related food reward pathways. No over-the-counter supplement replicates that mechanism.

Common OTC "appetite control" ingredients include glucomannan, green tea extract, caffeine, and chromium. A 2020 systematic review by Watford et al. in Obesity Reviews found that most commercially available weight-loss supplements showed minimal or statistically insignificant effects on appetite or body weight beyond placebo in randomized controlled trials. Glucomannan has modest supporting data for short-term satiety, but "modest" and "works like a GLP-1" are not the same sentence. Semaglutide trials, including the 2021 STEP 1 trial by Wilding et al. in The New England Journal of Medicine, showed a mean body weight reduction of 14.9% over 68 weeks. No supplement has come close to that in a comparable trial design.

What did they get wrong (or right)?

She got the problem right: postpartum and lifestyle-change-related snacking and weight gain are real, well-documented phenomena tied to stress hormones, disrupted sleep, and changes in routine. That context is valid.

What she got wrong is the implied equivalency. Saying she wants something that "works like the GLP-1" and then holding up a supplement treats these as interchangeable options. They are not. GLP-1 receptor agonists are FDA-approved, prescription medications with multi-year clinical trial data. A supplement with "Appetizer control" on the packaging is governed by DSHEA, meaning it does not have to prove efficacy before reaching store shelves.

There's also a subtle harm here. People who genuinely qualify for GLP-1 therapy, and many people in her position do, may delay or avoid pursuing a real clinical evaluation because they believe a cheaper OTC option is a reasonable substitute. That's not a small risk. Obesity is a chronic disease with serious downstream consequences, and the delay matters.

What should you actually know?

If you identify with what she described, constant snacking, weight gain during a life transition, difficulty controlling hunger, those are legitimate clinical symptoms worth discussing with a provider, not just a shopping trip problem.

GLP-1 receptor agonists are not magic, but they are the most effective pharmacological tools for appetite regulation currently available, with the evidence to back that up. Tirzepatide data from the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed up to 22.5% body weight reduction in adults with obesity. No supplement data exists in the same universe as those numbers.

That doesn't mean supplements are useless for everyone in every context. But the standard should be: does this ingredient have replicated, controlled trial evidence for appetite reduction in humans? For most products lining supplement store shelves, the honest answer is no. Read labels critically, and if hunger is genuinely disrupting your health, that conversation belongs with a licensed clinician, not a store aisle.